Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings From Women’s Empowerment Cancer Advocacy Network (WE CAN) Summits

PURPOSE Breast cancer civil society organizations have emerged in Eastern Europe and Central Asia to raise awareness about cancer as a survivable disease and provide patient support. We explored the experiences and priorities of these organizations with the goal of making recommendations to advance cancer advocacy and improve cancer care. METHODS We conducted in-depth interviews and focus group discussions with representatives of civil society organizations attending the 7th Women’s Empowerment Cancer Advocacy Network Summit in Romania in 2015. Interviews were audiorecorded, transcribed, coded, and analyzed for key themes. Findings were discussed at the 8th Women’s Empowerment Cancer Advocacy Network Summit in Ukraine in 2017 to ensure accuracy. RESULTS We conducted nine in-depth interviews and three focus group discussions with a total of 36 participants. Survivor- and oncologist-led organizations played an important role in filling existing gaps in public health care systems through awareness raising, patient support, and advocacy to improve early detection and access to treatment. Barriers to these efforts included persistent stigma, mistrust of patients toward the public health care system, limited access to evidence-based guidelines, difficulty adapting existing best practices to their setting, and insufficient involvement of policymakers. Key facilitators of advocacy efforts included effective local and international partnerships with physicians, like-minded organizations, and policymakers to facilitate access to educational resources, improve breast cancer early detection and care, and catalyze meaningful policy change. CONCLUSION Our findings highlight the value of providing opportunities for advocates to connect and share experiences. To advance cancer advocacy and improve cancer care, the following needs were identified: dissemination of resource-adapted information for improving outcomes; needs assessments; improved program-monitoring practices; and fostering and promotion of collaboration between advocates, medical professionals, and local governments.

[1]  O. Solà-Morales,et al.  Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe , 2020, Breast.

[2]  R. Carlson,et al.  NCCN resource‐stratified and harmonized guidelines: A paradigm for optimizing global cancer care , 2020, Cancer.

[3]  R. Carlson,et al.  The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource‐Stratified Phased Implementation: Methods and overview , 2020, Cancer.

[4]  J. Gralow,et al.  Breast cancer patient advocacy: A qualitative study of the challenges and opportunities for civil society organizations in low‐income and middle‐income countries , 2020, Cancer.

[5]  J. Zejda,et al.  Modes of Early Detection of Breast Cancer in Katowice Region, Poland , 2020, International journal of environmental research and public health.

[6]  J. Gralow,et al.  Patient Advocacy Approaches to Improving Care for Breast and Cervical Cancer in East and Southern Africa , 2020, JCO global oncology.

[7]  Z. R. Alikova,et al.  [The characteristics of morbidity of breast cancer in the Kabarda-Balkar Republic]. , 2020, Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny.

[8]  M. Mikoś,et al.  Causes of delays in breast cancer diagnosis in Poland. , 2019, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[9]  A. Śliwczyński,et al.  Improvement in outcomes of breast cancer patient treatment in Poland in the 21st century , 2019, The breast journal.

[10]  Grant Lewison,et al.  Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning. , 2018, European journal of cancer.

[11]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[12]  A. Eniu,et al.  Access to Affordable Breast Cancer Care in Eastern Europe , 2018, Current Breast Cancer Reports.

[13]  A. Chukmaitov,et al.  Analysis of Delays in Breast Cancer Treatment and Late-Stage Diagnosis in Kazakhstan , 2017, Asian Pacific journal of cancer prevention : APJCP.

[14]  V. Marconi,et al.  Code Saturation Versus Meaning Saturation , 2017, Qualitative health research.

[15]  B. Sikic,et al.  Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement. , 2016, The oncologist.

[16]  R. Fielding,et al.  Disparities in psychosocial cancer care: a report from the International Federation of Psycho‐oncology Societies , 2016, Psycho-oncology.

[17]  R. Sullivan,et al.  ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Rashmi Kumar,et al.  NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[19]  N. Lins,et al.  International Framework for Cancer Patient Advocacy: Empowering Organizations and Patients to Create a National Call to Action on Cancer , 2015, Journal of global oncology.

[20]  G. Galea,et al.  Cancer in Russia: reflections from WHO in Europe. , 2014, The Lancet. Oncology.

[21]  Jun Wang,et al.  Challenges to effective cancer control in China, India, and Russia. , 2014, The Lancet. Oncology.

[22]  L. P. Bass,et al.  The role of breast cancer civil society in different resource settings. , 2011, Breast.

[23]  J. Gralow,et al.  Breast cancer advocacy: changing perceptions. , 2009, Salud publica de Mexico.

[24]  Elizabeth M. Leitman,et al.  Building a Latin American cancer patient advocacy movement: Latin American cancer NGO regional overview. , 2009, Salud publica de Mexico.

[25]  Edward Azavedo,et al.  Guidelines for International Breast Health and Cancer Control – Implementation Supplement to Cancer Guideline Implementation for Breast Healthcare in Low-Income and Middle-Income Countries Overview of the Breast Health Global Initiative Global Summit 2007 , 2008 .

[26]  N. Grey,et al.  Cancer Control Opportunities in Low‐ and Middle‐income Countries , 2007, CA: a cancer journal for clinicians.

[27]  R. Carlson,et al.  Breast Cancer in Limited‐Resource Countries: An Overview of the Breast Health Global Initiative 2005 Guidelines , 2006, The breast journal.

[28]  L. Gilson Trust and the development of health care as a social institution. , 2003, Social science & medicine.

[29]  N. Suprun,et al.  Lives renewed: The emergence of a Breast cancer survivor movement in Ukraine , 2001, Reproductive health matters.

[30]  Eleanor McLellan,et al.  Codebook Development for Team-Based Qualitative Analysis , 1998 .

[31]  Alfred Wolff Cancer in Europe , 1903, The Indian medical gazette.

[32]  E. Huerta,et al.  THE FIFTH INTERNATIONAL CANCER CONTROL CONGRESS SESSION 2 : MOBILIZING “ ALL OF SOCIETY ” FOR EFFECTIVE CANCER CONTROL , 2014 .